財務情報
- Market Capitalization 4.83 M
- Employee 6
- Founded 2009
- CEO N/A
- Website www.kalarx.com
- Headquarter Delaware, United States
- FIGI BBG001J2MVT8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.17
売上高対価格比率
—
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4827 | XBIO Xenetic Biosciences, Inc. - Common Stock | 2.10 USD | 0.00% | -4.11% | -51.50% | -58.98% | 4.92 M USD | ||
| 4829 | AIM AIM ImmunoTech Inc. Common Stock | 0.16 USD | -5.88% | -15.79% | -27.27% | -93.87% | 4.87 M USD | ||
| 4837 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.67 USD | -5.65% | +15.97% | -14.36% | -24.94% | 4.66 M USD | ||
| 4843 | LEXX Lexaria Bioscience Corp. - Common Stock | 2.73 USD | -2.50% | -17.52% | -22.88% | +210.23% | 4.51 M USD |